Enthusiasm for the Slow Road

Where there is enthusiasm for addressing the process of aging in the life science research and funding communities, that enthusiasm is still overwhelmingly directed towards the slow, incremental road. Which is to say, plans such as: Modestly slow aging by reverse engineering calorie restriction to build a medication that captures some of its effects. Modestly slow aging by reverse engineering the difference between long-lived and short-lived people and build a medication that captures some of these effects. Modestly slow aging by reverse engineering the differences between long-lived and short-lived mammalian species and build a medication that captures some of these effects. These are all enormous projects of great complexity, stretching the bounds of the research community, that will likely take two or more decades to … Continue reading Enthusiasm for the Slow Road